Literature DB >> 19582818

Fine-needle aspiration (FNA) and pleural fluid cytology diagnosis of benign metastasizing pleomorphic adenoma of the parotid gland in the lung: a case report and review of literature.

Yaxia Zhang1, Carmen R Gomez-Fernandez, Merce Jorda, Parvin Ganjei-Azar.   

Abstract

Lesions that contain abundant benign myoepithelial cells, including pleomorphic adenomas of salivary gland origin, may present a diagnostic challenge in fine-needle aspiration (FNA) specimens. Benign metastasizing pleomorphic adenoma is a rare neoplasm, in which the benign appearing pleomorphic adenoma, without any histological evidence of malignancy, metastasizes to distant sites including lung. In the absence of clinical history of a pre-existing myoepithelial neoplasm, the presence of myoepithelial cells in the lung or any other organs besides salivary glands may create diagnostic difficulty. Here we present the cytologic findings of such a metastatic tumor found in the lung FNA and pleural fluid specimens from a 64-year-old woman, with a history of local recurrent salivary gland pleomorphic adenomas, who presented with multiple bilateral pulmonary nodules and pleural effusion. The diagnosis of benign metastasizing pleomorphic adenoma was made based on clinical information and cytomorphology, and confirmed by immunocytochemistry.

Entities:  

Mesh:

Year:  2009        PMID: 19582818     DOI: 10.1002/dc.21123

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  2 in total

1.  Metastatic pleomorphic adenoma to the supraspinatus muscle: a case report and review of a rare aggressive clinical entity.

Authors:  James G McGarry; Maeve Redmond; John B Tuffy; Lorraine Wilson; Seamus Looby
Journal:  J Radiol Case Rep       Date:  2015-10-31

2.  Pleural fluid metastases of salivary duct carcinoma: A case report and review of the literature.

Authors:  Julie Huss; Rachel Conrad; Sharon Hirschowitz; Neda Moatamed
Journal:  Cytojournal       Date:  2014-02-15       Impact factor: 2.091

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.